Catalyst Funds Management Pty LTD Viking Therapeutics, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 1,000 shares of VKTX stock, worth $55,060. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$55,060% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
468Shares Held
66.2MCall Options Held
5.32MPut Options Held
3.03M-
Vanguard Group Inc Valley Forge, PA10.2MShares$560 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$332 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$257 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$117 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$103 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.22B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...